2000
DOI: 10.1590/s0100-879x2000000800002
|View full text |Cite
|
Sign up to set email alerts
|

[No Title Available]

Abstract: A new concept in the therapy of both neoplastic and non-neoplastic diseases is discussed in this article. Photodynamic therapy (PDT) involves light activation, in the presence of molecular oxygen, of certain dyes that are taken up by the target tissue. These dyes are termed photosensitizers. The mechanism of interaction of the photosensitizers and light is discussed, along with the effects produced in the target tissue. The present status of clinical PDT is discussed along with the newer photosensitizers being… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
44
0
1

Year Published

2002
2002
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 148 publications
(45 citation statements)
references
References 52 publications
0
44
0
1
Order By: Relevance
“…This is surprising because porphyrin-mediated photosensitization has typically been attributed to their large yield for triplet state-sensitized singlet oxygen ( 1 O 2 ) or the formation of other ROS 22. These mechanisms are also commonly accepted as the major, if not the exclusive, contributors to the biomedical applications of porphyrins 17. However, our results suggest a new possibility for the mechanisms triggered by porphyrins interacting with biomolecules: an O 2 -independent, Type III photosensitization.…”
Section: Discussionmentioning
confidence: 77%
“…This is surprising because porphyrin-mediated photosensitization has typically been attributed to their large yield for triplet state-sensitized singlet oxygen ( 1 O 2 ) or the formation of other ROS 22. These mechanisms are also commonly accepted as the major, if not the exclusive, contributors to the biomedical applications of porphyrins 17. However, our results suggest a new possibility for the mechanisms triggered by porphyrins interacting with biomolecules: an O 2 -independent, Type III photosensitization.…”
Section: Discussionmentioning
confidence: 77%
“…Over the last few decades, photosensitizer (PS)-mediated photodynamic therapy (PDT) has been introduced as a possible alternative non-invasive localized therapeutic modality for treating cancer as well as cardiovascular, ophthalmic, dermatological, and dental diseases [1,2,3,4,5,6,7]. PDT is a two-step procedure that involves the administration of a photosensitizing agent [8], followed by activation of the drug with non-thermal light of a specific wavelength [9].…”
Section: Introductionmentioning
confidence: 99%
“…Among new therapies, photodynamic therapy (PDT) appears as a promising modality in cancer treatment with the lowest rates of side effects. Since the 1990s PDT has been investigated in basic research and showed to be more effective when nanostructured materials are used as the drug delivery system (DDS) for the active compounds [1-7]. Nowadays, interest in using PDT is increasing as a result of its recognition by the FDA (U.S. Food and Drug Administration) and other world agencies as an effective therapy for the treatment of several diseases, including cancer [8].…”
Section: Introductionmentioning
confidence: 99%
“…PDT is currently being used in the clinical phase for treatment of several types of tumors [9,10] around the world [11-14]. However, this therapy is particularly effective in the treatment of easily accessible lesions, such as non-melanoma skin cancers and lesions with well-defined borders [2], although it has been used outside oncology applications, including ophthalmology, dermatology, cardiology, virus inactivation, and blood purification [1]. …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation